CA2064993C - Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it - Google Patents
Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it Download PDFInfo
- Publication number
- CA2064993C CA2064993C CA002064993A CA2064993A CA2064993C CA 2064993 C CA2064993 C CA 2064993C CA 002064993 A CA002064993 A CA 002064993A CA 2064993 A CA2064993 A CA 2064993A CA 2064993 C CA2064993 C CA 2064993C
- Authority
- CA
- Canada
- Prior art keywords
- collagen
- sheet
- gel
- less
- mesh
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J5/00—Manufacture of articles or shaped materials containing macromolecular substances
- C08J5/18—Manufacture of films or sheets
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/32—Proteins, polypeptides; Degradation products or derivatives thereof, e.g. albumin, collagen, fibrin, gelatin
- A61L15/325—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
- A61L31/04—Macromolecular materials
- A61L31/043—Proteins; Polypeptides; Degradation products thereof
- A61L31/044—Collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
- B01D—SEPARATION
- B01D19/00—Degasification of liquids
- B01D19/0031—Degasification of liquids by filtration
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L89/00—Compositions of proteins; Compositions of derivatives thereof
- C08L89/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08L89/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin, e.g. gelatin
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
- C08J2389/00—Characterised by the use of proteins; Derivatives thereof
- C08J2389/04—Products derived from waste materials, e.g. horn, hoof or hair
- C08J2389/06—Products derived from waste materials, e.g. horn, hoof or hair derived from leather or skin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Materials Engineering (AREA)
- Pharmacology & Pharmacy (AREA)
- Polymers & Plastics (AREA)
- Dermatology (AREA)
- Manufacturing & Machinery (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Surgery (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Type I collagen gel with an H2O content not exceeding 20% by weight, in the form of a sheet of thickness between 0.02 and 2 mm, of compact transparent structure, with a capacity for absorbing aqueous biological liquids limited to a maximum of 15 times its weight, being free from native collagen degradation products, and suitable for the therapeutic treatment of wounds and burns.
Description
NON-POROUS COLLAGEN SHEET FOR THERAPEUTIC USE, AND THE METHOD AND
APPARATUS FOR PREPARING IT
Collagen is a scleroprotein widespread in nature. It represents about one third of the total proteins of the human body.
Medical practice has recently seen the introduction of the use of collagen as a stimulating agent in the cicatrization process involving an interaction effect with various growth factors, because of its capturing action on fibronectin, a glycoprotein which promotes cell attachment and the migration and replication of the resultant cells (see "I1 collageno nella cicatrizzazione" by $.
Palmieri, publ. Artestampa, January 1990, pp. 40-42) and other actions which are still not totally clear. The known collagen product, using a particular non-denaturing process, is prepared in stable form by a process of extraction from animal organs rich in this sclerpprotein, purification and subsequent lyophilization.
The final product is in the form of mats of greater or lesser thickness, characterised by high absorbent power (exudates and liquids in general) because of its structure in the form of fibres which are spaced apart and branched in such a manner as to make a large specific surface available for absorption (up to 50 times its weight). The hydrophilic nature of collagen also greatly favours this absorbent power.
In addition to the aforesaid function, the role of collagen in cicatrization is characterised by collagen/platelet interaction and the formation of a bond between the collagen, the fibronectin and the growth factors, molecules which are known to be implicated in regulating the cicatrization process (see pages 45-46 of the aforesaid text}.
There are however cases in which the absorbent formation of the collagen sponge and its hydrophilic nature lead to an excessive loss of physiological liquids. It is well known that an evaporation process normally occurs through the undamaged skin, and this increases considerably in the case of skin lesion, resulting in dehydration of the underlying layers. The phenomenon is IO accentuated for example in burn cases, when large skin ;portions are damaged traumatically. In this case the absorbent: effect.of lyophilized collagen further increases the process of evaporation, with consequent damage to the underlying structure.
The present invention provides a product which while maintaining the rapid cicatrization characteristics of collagen, at the same time prevents excessive evaporation, allows constant inspection of the bed of the wound without having to be removed (transparency), is simple and practical to use, adheres satisfactorily to the injured surface, does not require frequent replacement, can transpire to allow oxygenation of the bed of the wound while preventing its contamination by bacteria, is absorbable but not soluble in the biological liquids with which it comes into contact, unless by specific enzymatic action, and is structurally homogeneous.
2a More specifically, the present invention provides a non-porous sheet of type I
collagen gel, suitable for the therapeutic cicatrizing treatment of wounds and burns, the sheet being free from native collagen degradation products, having an H20 content not exceeding 20% by weight, a thickness, comprised between 0.02 and 2 mm, which is uniform over the entire surface of the sheet, the; sheet being characterized in that it is of transparent structure, it has an homogeneous structure, it has the classical triple-helical structure of native collagen, it comprises gas bubbles with a diameter of less than 0.034 mm under atmospheric pressure, it has a capacity for absorbing aqueous biological liquids limited to a maximum of 15 times its weight and a high resistance to enzymatic attack.
Another important characteristic of the collagen according to the invention is that of being suitable as interposition material for preventing accretions in the internal surgery operations.
To obtain a product with these characteristics, type I collagen was used as defined in Table 1 on page 3 of the aforestated text, this having the characteristic of being insoluble in the various types of biological liquids. Type I collagen present in the skin represents about 80% of the total located in the deep dermis, 90-95% in the tendons and 100% in the bones. Type I collagen is therefore the most biologically similar to that present in the human skin.
Because of its insolubility, in order to obtain a product of homogeneous structure, use was made of the known method of dispersing fibrous collagen in a dilute acetic acid solution of about pH 2.5 and maintaining agitation until a good dispersion of the collagen fibres in the liquid is obtained. At this pH value the fibres swell to form a gel. The gel obtained, still comprising fibre fractions which have not completely gelled and possibly corpuscles of extraneous substances, is further diluted with an acetic acid solution of pH 2.5-3.5 until a sufficiently fluid mass is obtained, which is then filtered.
The filtering, which is done under vacuum, uses a special Filter, indicative (but not liroitative) characteristics of which are given hereinafter, and allows practically total elimination of the inevitable air bubbles which form during gelling and are difficult to eliminate given the viscosity of collagen gel.
By the effect of the vacuum, which has to be of the order of 30 mmHg residual pressure, these bubbles increase their volume, the passage through the mesh then breaks down and eliminates them. It has been found experimentally that the best filtration conditions to achieve the described phenomenon are a gel temperature of 10-30°C, preferably 25-28°C, and a residual vacuum of 20-60 mmHg, preferably about 30 mmHg.
These data are indicative and have been found experimentally to be the most effective, although not representing a limitation on the operating conditions of this process.
l0 The filtered gel is collected in a closed vessel maintained under vacuum and constructed in such a manner that the filtered gel runs along vessel partition walls located below the filter mesh and structured to produce a continuous liquid film which does not allow further air absorption after filtration, following inclusion of air bubbles.
The filtered gel is further maintained under vacuum at 20-25 mmkIg for a further hour to allow total elimination of any air bubbles which may still be present in the gel.
FILTER APPARATUS
The filter required for filtering the collagen gel, which besides eliminating the solid particles, which are retained on the mesh, also eliminates the air bubbles contained in it, consists of an upper cylindrical stainless steel shell provided with a scraping stirrer to keep the collagen gel mixed and to remove solid particles from the mesh so that they do not clog it. The bottom of the cylindrical shell houses a stainless steel mesh with a mesh s~~~~'~i.~ra size of less than 0.1 mm (Taurail meshes have been found to be particularly effective).
The lower part (below the mesh) consists of a cylindrical shell in which vacuum can be generated by a suitable pump. The air bubbles 5 contained in the gel which filters through the mesh increase considerably in volume because of the vacuum.
At about 3 mm below the filter mesh there is a device consisting of a series of stainless steel plates which are vertically or raking placed and parallel between them. The filtered gel descends along these plates in the form of a continuous liquid film and runs by gravity towards the bottom of the vessel.
Those air bubbles which do not break down by the effect of the reduced pressure remain mainly in the upper part of the device whereas the gel, now free or almost free of air, runs to the bottom of the vessel. Any very small bubbles still present in the filtered gel decrease considerably in volume when returned to atmospheric pressure, so that they become practically absent.
In this respect, during filtration because of the difference between the pressure of the gel environment before filtration and the residual pressure below the mesh (about 30 mmHg), the bubble volume increases more than 25 times. Likewise, on passing from vacuum to the environmental pressure the bubble volume decreases 25 times. Hence the air bubbles of diameter less than 0.100 mm (advisable mesh passage size) have a diameter of less than 0.034 mm when returned to atmospheric pressure, ie are practically a r ~.~~~.~~ia s invisible. During drying, these residual bubbles are eliminated without leaving appreciable craters in the structure of the obtained sheet.
This means that extremely uniform thicknesses can be obtained over the entire sheet surface, so avoiding any porosity which could represent a point of preferential attack by enzymatic action, which would annul the protective effect against invasion by micro organisms.
DRYING
The filtered gel obtained as described, free from extraneous particles and air bubbles and perfectly clear and transparent, can then be used for preparing films of desired thickness and diameter.
For this, after analysis to exactly determine the concentration of the filtered gel, exactly measured quantities for obtaining films with the desired collagen thickness must be metered into suitable containers. This metering is generally effected by a suitable peristaltic pump which prevents incorporating air into the gel while at the same time preventing heating or friction which could damage the structure of the collagen protein. The containers are of tray shape and are formed of antiadherent material.
The described trays loaded with the gel in a controlled environment (relative humidity 60-80%, temperature 20-22'C, environment class 10,000 or less) are placed in a suitable controlled drying oven where they are left to stand for at least two hours to obtain perfect gel thickness uniformity. The oven is purged with a nitrogen stream for about 30 minutes to totally eliminate air and ~e~~E~:~ty'u x' ~ C 2 4~/
remove oxygen, in order to ensure constant operating conditions and prevent possible oxidation.
This operation has also been shown to practically totally block the growth of micro-organism colonies, which sometimes occurs if the procedure is carried out with air present in the environment.
Drying is effected in a nitrogen stream under closed cycle.
The drying, being the critical stage for obtaining films with the desired characteristics, is conducted under particular conditions in an appropriate oven shown schematically in Figure 1.
In this, the reference numeral 1 indicates the drying trays resting on perforated side wails, V indicates the fan for circulating nitrogen through the apparatus, N2 indicates the nitrogen feed valve, GF indicates the refrigeration unit with coil, S represents a parallel plate device for separating condensate droplets, T1 indicates a first thermometer, SC indicates the condensed water discharge, R indicates the heating device, T2 indicates a second thermometer, I1 indicates a first hygrometer, 1~0 indicates an oxygen meter (analyzer), Sg indicates the gas discharge, Tr indicates an overpressure trap and I2 indicates a second hygrometer.
The oven is arranged in this manner to satisfy the following requirements:
1) the facility for eliminating air by purging with nitrogen to a residual oxygen content of less than 2~;
2) the facility for varying the nitrogen cooling and heating s,~~~L.~a~~7~a temperature to a maximum of 30°C, to control the relative humidity in the drying chamber and the water evaporation rate;
APPARATUS FOR PREPARING IT
Collagen is a scleroprotein widespread in nature. It represents about one third of the total proteins of the human body.
Medical practice has recently seen the introduction of the use of collagen as a stimulating agent in the cicatrization process involving an interaction effect with various growth factors, because of its capturing action on fibronectin, a glycoprotein which promotes cell attachment and the migration and replication of the resultant cells (see "I1 collageno nella cicatrizzazione" by $.
Palmieri, publ. Artestampa, January 1990, pp. 40-42) and other actions which are still not totally clear. The known collagen product, using a particular non-denaturing process, is prepared in stable form by a process of extraction from animal organs rich in this sclerpprotein, purification and subsequent lyophilization.
The final product is in the form of mats of greater or lesser thickness, characterised by high absorbent power (exudates and liquids in general) because of its structure in the form of fibres which are spaced apart and branched in such a manner as to make a large specific surface available for absorption (up to 50 times its weight). The hydrophilic nature of collagen also greatly favours this absorbent power.
In addition to the aforesaid function, the role of collagen in cicatrization is characterised by collagen/platelet interaction and the formation of a bond between the collagen, the fibronectin and the growth factors, molecules which are known to be implicated in regulating the cicatrization process (see pages 45-46 of the aforesaid text}.
There are however cases in which the absorbent formation of the collagen sponge and its hydrophilic nature lead to an excessive loss of physiological liquids. It is well known that an evaporation process normally occurs through the undamaged skin, and this increases considerably in the case of skin lesion, resulting in dehydration of the underlying layers. The phenomenon is IO accentuated for example in burn cases, when large skin ;portions are damaged traumatically. In this case the absorbent: effect.of lyophilized collagen further increases the process of evaporation, with consequent damage to the underlying structure.
The present invention provides a product which while maintaining the rapid cicatrization characteristics of collagen, at the same time prevents excessive evaporation, allows constant inspection of the bed of the wound without having to be removed (transparency), is simple and practical to use, adheres satisfactorily to the injured surface, does not require frequent replacement, can transpire to allow oxygenation of the bed of the wound while preventing its contamination by bacteria, is absorbable but not soluble in the biological liquids with which it comes into contact, unless by specific enzymatic action, and is structurally homogeneous.
2a More specifically, the present invention provides a non-porous sheet of type I
collagen gel, suitable for the therapeutic cicatrizing treatment of wounds and burns, the sheet being free from native collagen degradation products, having an H20 content not exceeding 20% by weight, a thickness, comprised between 0.02 and 2 mm, which is uniform over the entire surface of the sheet, the; sheet being characterized in that it is of transparent structure, it has an homogeneous structure, it has the classical triple-helical structure of native collagen, it comprises gas bubbles with a diameter of less than 0.034 mm under atmospheric pressure, it has a capacity for absorbing aqueous biological liquids limited to a maximum of 15 times its weight and a high resistance to enzymatic attack.
Another important characteristic of the collagen according to the invention is that of being suitable as interposition material for preventing accretions in the internal surgery operations.
To obtain a product with these characteristics, type I collagen was used as defined in Table 1 on page 3 of the aforestated text, this having the characteristic of being insoluble in the various types of biological liquids. Type I collagen present in the skin represents about 80% of the total located in the deep dermis, 90-95% in the tendons and 100% in the bones. Type I collagen is therefore the most biologically similar to that present in the human skin.
Because of its insolubility, in order to obtain a product of homogeneous structure, use was made of the known method of dispersing fibrous collagen in a dilute acetic acid solution of about pH 2.5 and maintaining agitation until a good dispersion of the collagen fibres in the liquid is obtained. At this pH value the fibres swell to form a gel. The gel obtained, still comprising fibre fractions which have not completely gelled and possibly corpuscles of extraneous substances, is further diluted with an acetic acid solution of pH 2.5-3.5 until a sufficiently fluid mass is obtained, which is then filtered.
The filtering, which is done under vacuum, uses a special Filter, indicative (but not liroitative) characteristics of which are given hereinafter, and allows practically total elimination of the inevitable air bubbles which form during gelling and are difficult to eliminate given the viscosity of collagen gel.
By the effect of the vacuum, which has to be of the order of 30 mmHg residual pressure, these bubbles increase their volume, the passage through the mesh then breaks down and eliminates them. It has been found experimentally that the best filtration conditions to achieve the described phenomenon are a gel temperature of 10-30°C, preferably 25-28°C, and a residual vacuum of 20-60 mmHg, preferably about 30 mmHg.
These data are indicative and have been found experimentally to be the most effective, although not representing a limitation on the operating conditions of this process.
l0 The filtered gel is collected in a closed vessel maintained under vacuum and constructed in such a manner that the filtered gel runs along vessel partition walls located below the filter mesh and structured to produce a continuous liquid film which does not allow further air absorption after filtration, following inclusion of air bubbles.
The filtered gel is further maintained under vacuum at 20-25 mmkIg for a further hour to allow total elimination of any air bubbles which may still be present in the gel.
FILTER APPARATUS
The filter required for filtering the collagen gel, which besides eliminating the solid particles, which are retained on the mesh, also eliminates the air bubbles contained in it, consists of an upper cylindrical stainless steel shell provided with a scraping stirrer to keep the collagen gel mixed and to remove solid particles from the mesh so that they do not clog it. The bottom of the cylindrical shell houses a stainless steel mesh with a mesh s~~~~'~i.~ra size of less than 0.1 mm (Taurail meshes have been found to be particularly effective).
The lower part (below the mesh) consists of a cylindrical shell in which vacuum can be generated by a suitable pump. The air bubbles 5 contained in the gel which filters through the mesh increase considerably in volume because of the vacuum.
At about 3 mm below the filter mesh there is a device consisting of a series of stainless steel plates which are vertically or raking placed and parallel between them. The filtered gel descends along these plates in the form of a continuous liquid film and runs by gravity towards the bottom of the vessel.
Those air bubbles which do not break down by the effect of the reduced pressure remain mainly in the upper part of the device whereas the gel, now free or almost free of air, runs to the bottom of the vessel. Any very small bubbles still present in the filtered gel decrease considerably in volume when returned to atmospheric pressure, so that they become practically absent.
In this respect, during filtration because of the difference between the pressure of the gel environment before filtration and the residual pressure below the mesh (about 30 mmHg), the bubble volume increases more than 25 times. Likewise, on passing from vacuum to the environmental pressure the bubble volume decreases 25 times. Hence the air bubbles of diameter less than 0.100 mm (advisable mesh passage size) have a diameter of less than 0.034 mm when returned to atmospheric pressure, ie are practically a r ~.~~~.~~ia s invisible. During drying, these residual bubbles are eliminated without leaving appreciable craters in the structure of the obtained sheet.
This means that extremely uniform thicknesses can be obtained over the entire sheet surface, so avoiding any porosity which could represent a point of preferential attack by enzymatic action, which would annul the protective effect against invasion by micro organisms.
DRYING
The filtered gel obtained as described, free from extraneous particles and air bubbles and perfectly clear and transparent, can then be used for preparing films of desired thickness and diameter.
For this, after analysis to exactly determine the concentration of the filtered gel, exactly measured quantities for obtaining films with the desired collagen thickness must be metered into suitable containers. This metering is generally effected by a suitable peristaltic pump which prevents incorporating air into the gel while at the same time preventing heating or friction which could damage the structure of the collagen protein. The containers are of tray shape and are formed of antiadherent material.
The described trays loaded with the gel in a controlled environment (relative humidity 60-80%, temperature 20-22'C, environment class 10,000 or less) are placed in a suitable controlled drying oven where they are left to stand for at least two hours to obtain perfect gel thickness uniformity. The oven is purged with a nitrogen stream for about 30 minutes to totally eliminate air and ~e~~E~:~ty'u x' ~ C 2 4~/
remove oxygen, in order to ensure constant operating conditions and prevent possible oxidation.
This operation has also been shown to practically totally block the growth of micro-organism colonies, which sometimes occurs if the procedure is carried out with air present in the environment.
Drying is effected in a nitrogen stream under closed cycle.
The drying, being the critical stage for obtaining films with the desired characteristics, is conducted under particular conditions in an appropriate oven shown schematically in Figure 1.
In this, the reference numeral 1 indicates the drying trays resting on perforated side wails, V indicates the fan for circulating nitrogen through the apparatus, N2 indicates the nitrogen feed valve, GF indicates the refrigeration unit with coil, S represents a parallel plate device for separating condensate droplets, T1 indicates a first thermometer, SC indicates the condensed water discharge, R indicates the heating device, T2 indicates a second thermometer, I1 indicates a first hygrometer, 1~0 indicates an oxygen meter (analyzer), Sg indicates the gas discharge, Tr indicates an overpressure trap and I2 indicates a second hygrometer.
The oven is arranged in this manner to satisfy the following requirements:
1) the facility for eliminating air by purging with nitrogen to a residual oxygen content of less than 2~;
2) the facility for varying the nitrogen cooling and heating s,~~~L.~a~~7~a temperature to a maximum of 30°C, to control the relative humidity in the drying chamber and the water evaporation rate;
3) the Facility for regulating the rate of nitrogen circulation through the chamber so as not to create high flow points and hence maintain a uniform drying rate over the entire surface and prevent the formation of creases which, besides being undesirable from the appearance aspect, are an indication of different collagen concentrations and poor homogeneity of drying (localized drying), The H20 content of the product must not be higher than 20% by lp weight. It is preferable to achieve a higher level of drying (down to 2% or 3% of H20), in particular to ensure proper elimination of the acetic acid present in the initial gel. The dried product obtained easily reabsorbs moisture from the environment, while being maintained within the maximum limit of 20%.
EXAMPLE
The conditions found experimentally to be most appropriate far conducting a drying cycle are given below by way of non-limiting example.
1st stage:
2d Nitrogen purging until the oxygen content 3s less than 1%, standing for two hours to come to equilibrium, loaded gel level 10 mm, gel collagen concentration 0.5%.
2nd stage:
Starting of nitrogen circulation by fan.
Nitrogen temperature after cooling -5°C (T1).
Nitrogen temperature after heating 26-28°C (T2).
g Time about 12 hours.
Relative humidity entry to drying region (point I1) 12-1L4%.
Relative humidity exit of drying region (point I2) '70-80%.
3rd stage:
Nitrogen temperature after cooling -15~C (T1).
Nitrogen temperature after heating 26-2$~C (T2).
Time about 12 hours.
Relative humidity entry to drying region (point I1) 6-~%.
Relative humidity exit of drying region (point I2) 45-50%.
4th stage:
Final drying Nitrogen temperature after cooling -40'C (T1).
Nitrogen temperature after heating 26-28~C (T2).
Time about 12 hours.
Z5 5th stage:
Product discharge, preparation of a new load. Complete removal of water from the cooling coil and purging the oven by nitrogen circulation at '~0-80~C for two hours, cooling to 20'C and loading new product.
The nitrogen flow rate through the drier is adjusted on the basis of the required degree of drying.
A semi-transparent film with a thickness of about 200 micron is obtained. The thickness can vary in general between 0.02 and 2 mm.
This represents a non-specific item for the purposes of the therapeutic application as it determines only the product /'. ~~ . ' '..
9,~ ~ t:t c~ zf cb absorption time but not its specific characteristics. The degree of drying can also vary as stated.
The characteristics of the film obtained are:
- maintaining of the "native" structure of collagen fibre (the 5 classical triple spiral structure of collagen has been demonstrated by the electron microscope) - absence of degradation products such as monomers or dimers of collagen not organized into fibrils, or gelatin, an indication of potential allergenicity 10 ° high protein nitrogen content (exceeding 900) - high hydroxyproline content (exceeding 12%) - low absorbent power (about 10-15 times its weight against 50 times for the lyophilized product of the known art) - high resistance to enzymatic attack - good product transparency - excellent plasticity after immersion in physiological solution.
The product obtained in this manner is sterilized by irradiation with gamma rays and used in the treatment of burns and generally all. cases of skin removal or damage.
The result is excellent both in terms of tolerance (no case of allergenicity or hypersensitivity to the medicament has been recorded, the native characteristic of the product remaining unaltered during the process) and in terms of pain attenuation.
The cicatrization time is very rapid acid product absorption considerably longer compared with equivalent treatment using lyophilized collagen (sponge) and consequently there is lesser need ~~~x~~r to replace it. Exudate lass is very low, and much lower than that when using lyophilized collagen.
The transparency of the product means that the progress of the injury can be viewed without the need to remove the collagen sheet (generally a painful procedure).
The product can be presented in the form of sheets of different dimensions (square, rectangular, round, elliptical or others) supported or not supported by adhesives (such as plasters) or by sheets of inert substances such as nylon, polyurethane, polyethylene etc., or associated during the drying process, or subsequently, with pharmacologically active substances.
EXAMPLE
The conditions found experimentally to be most appropriate far conducting a drying cycle are given below by way of non-limiting example.
1st stage:
2d Nitrogen purging until the oxygen content 3s less than 1%, standing for two hours to come to equilibrium, loaded gel level 10 mm, gel collagen concentration 0.5%.
2nd stage:
Starting of nitrogen circulation by fan.
Nitrogen temperature after cooling -5°C (T1).
Nitrogen temperature after heating 26-28°C (T2).
g Time about 12 hours.
Relative humidity entry to drying region (point I1) 12-1L4%.
Relative humidity exit of drying region (point I2) '70-80%.
3rd stage:
Nitrogen temperature after cooling -15~C (T1).
Nitrogen temperature after heating 26-2$~C (T2).
Time about 12 hours.
Relative humidity entry to drying region (point I1) 6-~%.
Relative humidity exit of drying region (point I2) 45-50%.
4th stage:
Final drying Nitrogen temperature after cooling -40'C (T1).
Nitrogen temperature after heating 26-28~C (T2).
Time about 12 hours.
Z5 5th stage:
Product discharge, preparation of a new load. Complete removal of water from the cooling coil and purging the oven by nitrogen circulation at '~0-80~C for two hours, cooling to 20'C and loading new product.
The nitrogen flow rate through the drier is adjusted on the basis of the required degree of drying.
A semi-transparent film with a thickness of about 200 micron is obtained. The thickness can vary in general between 0.02 and 2 mm.
This represents a non-specific item for the purposes of the therapeutic application as it determines only the product /'. ~~ . ' '..
9,~ ~ t:t c~ zf cb absorption time but not its specific characteristics. The degree of drying can also vary as stated.
The characteristics of the film obtained are:
- maintaining of the "native" structure of collagen fibre (the 5 classical triple spiral structure of collagen has been demonstrated by the electron microscope) - absence of degradation products such as monomers or dimers of collagen not organized into fibrils, or gelatin, an indication of potential allergenicity 10 ° high protein nitrogen content (exceeding 900) - high hydroxyproline content (exceeding 12%) - low absorbent power (about 10-15 times its weight against 50 times for the lyophilized product of the known art) - high resistance to enzymatic attack - good product transparency - excellent plasticity after immersion in physiological solution.
The product obtained in this manner is sterilized by irradiation with gamma rays and used in the treatment of burns and generally all. cases of skin removal or damage.
The result is excellent both in terms of tolerance (no case of allergenicity or hypersensitivity to the medicament has been recorded, the native characteristic of the product remaining unaltered during the process) and in terms of pain attenuation.
The cicatrization time is very rapid acid product absorption considerably longer compared with equivalent treatment using lyophilized collagen (sponge) and consequently there is lesser need ~~~x~~r to replace it. Exudate lass is very low, and much lower than that when using lyophilized collagen.
The transparency of the product means that the progress of the injury can be viewed without the need to remove the collagen sheet (generally a painful procedure).
The product can be presented in the form of sheets of different dimensions (square, rectangular, round, elliptical or others) supported or not supported by adhesives (such as plasters) or by sheets of inert substances such as nylon, polyurethane, polyethylene etc., or associated during the drying process, or subsequently, with pharmacologically active substances.
Claims (4)
1. A non-porous sheet of type I collagen gel, suitable for the therapeutic cicatrizing treatment of wounds and burns, said sheet being free from native collagen degradation products, having an H20 content not exceeding 20% by weight, a thickness, comprised between 0.02 and 2 mm, which is uniform over the entire surface of the sheet, said sheet being characterized in that it is of transparent structure, it has an homogeneous stricture, it has the classical triple-helical structure of native collagen, it comprises gas bubbles with a diameter of less than 0.034 mm under atmospheric pressure, it has a capacity for absorbing aqueous biological liquids limited to a maximum of 15 times its weight and a high resistance to enzymatic attack.
2. A method of preparing a sheet of type I collagen as claimed in claim 1 from aqueous diluted collagen gel of pH 2.5-3.5, the method comprising filtering the gel through a filter apparatus having a filter surface with a passage size of less than 0.1 mm, the lower part of the filtering apparatus being under a vacuum of 2666-7998 Pa and provided in the region immediately below the filter mesh with a device consisting of a series of plates vertically or raking placed and parallel between them, then drying the liquid gel contained in trays by purging with nitrogen to a residual oxygen content of less than 2%, at a temperature of 20-22°C and with a relative humidity of 60-80%.
3. An apparatus suitable for filtering under vacuum a collagen gel in accordance with the filtering step defined in claim 2, the apparatus comprising an upper shell provided with a scraping stirrer, a metal mesh with a mesh size of less than 0.1 mm placed at the bottom of the upper shell, a lower shell connected with a vacuum pump, and provided in the region immediately below the filter mesh with a pack of plates vertically or raking placed and parallel between them for the purpose of conveying the filtrate constituted by the said collagen gel as a continuous liquid film.
4. Use of the sheet of type I collagen as claimed in claim 1, for the treatment of wounds and burns and as interposition material for preventing accretions in the internal surgery operations.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT91A001423 | 1991-05-23 | ||
ITMI911423A IT1249315B (en) | 1991-05-23 | 1991-05-23 | NON-POROUS COLLAGEN PLATE FOR THERAPEUTIC USE, METHOD AND EQUIPMENT TO OBTAIN IT |
Publications (2)
Publication Number | Publication Date |
---|---|
CA2064993A1 CA2064993A1 (en) | 1992-11-24 |
CA2064993C true CA2064993C (en) | 2005-01-18 |
Family
ID=11359972
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002064993A Expired - Fee Related CA2064993C (en) | 1991-05-23 | 1992-04-02 | Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0514691B1 (en) |
JP (1) | JP3423330B2 (en) |
KR (1) | KR100229304B1 (en) |
CN (1) | CN1066790A (en) |
AT (1) | ATE132517T1 (en) |
CA (1) | CA2064993C (en) |
DE (1) | DE69207263T2 (en) |
IT (1) | IT1249315B (en) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6309454B1 (en) | 2000-05-12 | 2001-10-30 | Johnson & Johnson Medical Limited | Freeze-dried composite materials and processes for the production thereof |
US20190328679A1 (en) | 2001-10-12 | 2019-10-31 | Aquestive Therapeutics, Inc. | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US8663687B2 (en) | 2001-10-12 | 2014-03-04 | Monosol Rx, Llc | Film compositions for delivery of actives |
US7666337B2 (en) | 2002-04-11 | 2010-02-23 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
US8765167B2 (en) | 2001-10-12 | 2014-07-01 | Monosol Rx, Llc | Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions |
US7357891B2 (en) | 2001-10-12 | 2008-04-15 | Monosol Rx, Llc | Process for making an ingestible film |
US7425292B2 (en) | 2001-10-12 | 2008-09-16 | Monosol Rx, Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
US8900498B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for manufacturing a resulting multi-layer pharmaceutical film |
US7910641B2 (en) | 2001-10-12 | 2011-03-22 | Monosol Rx, Llc | PH modulated films for delivery of actives |
US10285910B2 (en) | 2001-10-12 | 2019-05-14 | Aquestive Therapeutics, Inc. | Sublingual and buccal film compositions |
US20110033542A1 (en) | 2009-08-07 | 2011-02-10 | Monosol Rx, Llc | Sublingual and buccal film compositions |
US8900497B2 (en) | 2001-10-12 | 2014-12-02 | Monosol Rx, Llc | Process for making a film having a substantially uniform distribution of components |
EP1463491B1 (en) * | 2001-10-12 | 2012-09-12 | MonoSolRX, LLC | Thin film with non-self-aggregating uniform heterogeneity, process for ther production and drug delivery systems made therefrom |
US20070281003A1 (en) | 2001-10-12 | 2007-12-06 | Fuisz Richard C | Polymer-Based Films and Drug Delivery Systems Made Therefrom |
US11207805B2 (en) | 2001-10-12 | 2021-12-28 | Aquestive Therapeutics, Inc. | Process for manufacturing a resulting pharmaceutical film |
US8603514B2 (en) | 2002-04-11 | 2013-12-10 | Monosol Rx, Llc | Uniform films for rapid dissolve dosage form incorporating taste-masking compositions |
US8017150B2 (en) | 2002-04-11 | 2011-09-13 | Monosol Rx, Llc | Polyethylene oxide-based films and drug delivery systems made therefrom |
WO2004066986A1 (en) * | 2003-01-30 | 2004-08-12 | Monosolrx Llc | Thin film with non-self-aggregating uniform heterogeneity and drug delivery systems made therefrom |
EP3210601A1 (en) * | 2003-05-28 | 2017-08-30 | MonoSolRX, LLC | Polyethylene oxide-based films and drug delivery system made therefrom |
JP4621563B2 (en) * | 2005-08-26 | 2011-01-26 | 新田ゼラチン株式会社 | Skin retention sheet |
WO2008036299A2 (en) | 2006-09-20 | 2008-03-27 | Monosol Rx Llc | Edible water-soluble film containing a foam reducing flavoring agent |
CA2674524C (en) | 2006-12-22 | 2014-05-20 | Laboratoire Medidom S.A. | In situ system for intra-articular chondral and osseous tissue repair |
US8475832B2 (en) | 2009-08-07 | 2013-07-02 | Rb Pharmaceuticals Limited | Sublingual and buccal film compositions |
WO2011156711A1 (en) | 2010-06-10 | 2011-12-15 | Schobel Alexander M | Nanoparticle film delivery systems |
US9149959B2 (en) | 2010-10-22 | 2015-10-06 | Monosol Rx, Llc | Manufacturing of small film strips |
US11191737B2 (en) | 2016-05-05 | 2021-12-07 | Aquestive Therapeutics, Inc. | Enhanced delivery epinephrine compositions |
US11273131B2 (en) | 2016-05-05 | 2022-03-15 | Aquestive Therapeutics, Inc. | Pharmaceutical compositions with enhanced permeation |
CN109364570B (en) | 2018-12-19 | 2021-02-02 | 武汉华星光电半导体显示技术有限公司 | Filtering device and filtering method |
JP7311983B2 (en) * | 2019-03-01 | 2023-07-20 | 大日本印刷株式会社 | Gel membrane manufacturing method and gel membrane |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR1596789A (en) * | 1968-11-27 | 1970-06-22 | ||
IT946066B (en) * | 1971-11-17 | 1973-05-21 | Sir Soc Italiana Resine Spa | CATALYSTS FOR THE PRODUCTION OF ETHYLENE OXIDE BY ETHYLENE OXYDATION |
US4600533A (en) * | 1984-12-24 | 1986-07-15 | Collagen Corporation | Collagen membranes for medical use |
US4948540A (en) * | 1988-08-01 | 1990-08-14 | Semex Medical, Inc. | Method of preparing collagen dressing sheet material |
-
1991
- 1991-05-23 IT ITMI911423A patent/IT1249315B/en active IP Right Grant
-
1992
- 1992-03-26 JP JP09861892A patent/JP3423330B2/en not_active Expired - Fee Related
- 1992-03-27 KR KR1019920005043A patent/KR100229304B1/en not_active IP Right Cessation
- 1992-04-01 CN CN92102332A patent/CN1066790A/en active Pending
- 1992-04-02 CA CA002064993A patent/CA2064993C/en not_active Expired - Fee Related
- 1992-04-29 DE DE69207263T patent/DE69207263T2/en not_active Expired - Lifetime
- 1992-04-29 EP EP92107249A patent/EP0514691B1/en not_active Expired - Lifetime
- 1992-04-29 AT AT92107249T patent/ATE132517T1/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
ITMI911423A0 (en) | 1991-05-23 |
IT1249315B (en) | 1995-02-22 |
EP0514691B1 (en) | 1996-01-03 |
JP3423330B2 (en) | 2003-07-07 |
KR920021161A (en) | 1992-12-18 |
EP0514691A3 (en) | 1993-03-31 |
KR100229304B1 (en) | 1999-11-01 |
ITMI911423A1 (en) | 1992-11-23 |
EP0514691A2 (en) | 1992-11-25 |
JPH05117162A (en) | 1993-05-14 |
DE69207263D1 (en) | 1996-02-15 |
DE69207263T2 (en) | 1996-05-15 |
CN1066790A (en) | 1992-12-09 |
CA2064993A1 (en) | 1992-11-24 |
ATE132517T1 (en) | 1996-01-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2064993C (en) | Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it | |
US5785983A (en) | Non-porous collagen sheet for therapeutic use, and the method and apparatus for preparing it | |
JP2834155B2 (en) | Collagen flake body | |
JP5689023B2 (en) | Surgical device for skin treatment or examination | |
US7098315B2 (en) | Method of preparing a collagen sponge, a device for extracting a part of a collagen foam, and an elongated collagen sponge | |
US6969523B1 (en) | Collagen/glycosaminoglycan matrix stable to sterilizing by electron beam radiation | |
DE60203264T2 (en) | Microbial cellulose wound dressing for the treatment of chronic wounds | |
EP1640024A2 (en) | Cell-coated support | |
JPH02504221A (en) | Cell culture methods, culture products and culture products | |
CN111166931A (en) | Methacrylic acid sericin/chitosan quaternary ammonium salt hydrogel and preparation method and application thereof | |
RU2437681C1 (en) | Wound covering with therapeutic action | |
KR20030060458A (en) | Method for the preparation of hydrogels for wound dressings | |
JP4486304B2 (en) | Microbial cellulosic wound dressings for the treatment of chronic wounds | |
US11400120B2 (en) | Composition comprising collagen and honey | |
CN112007210A (en) | Photoinitiated polyethylene glycol-based hydrogel dressing and preparation method thereof | |
CN110694111A (en) | Method for removing cells from organism tissue under non-denaturing condition | |
RU2254145C1 (en) | Wound coat based on collagen-chitosan complex | |
CN112023110B (en) | Active antibacterial dressing based on bamboo fungus egg extract | |
Denkbas et al. | EGF loaded chitosan sponges as wound dressing material | |
JPH0759812A (en) | Wound cover material and its production | |
CN118593572A (en) | Skin repair liquid containing stem cell factor and preparation method thereof | |
Macagonova et al. | Antigenic and Biodegradable Characteristics of the Extracellular Matrices from the Pig Dermis | |
CN117487188A (en) | Collagen grafted product with adjustable grafting rate and preparation method and application thereof | |
RU2342163C1 (en) | Means for cell replacement therapy | |
Bentley et al. | Liquid Collagen Wound Coverings. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
MKLA | Lapsed |